Active Clinical Trials

Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.

Showing 176 results
  • Sort by Sort ascending
  • Study title
  • Condition
  • Phase
  • Location
Study title Condition Phase Location

Study to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Grade 1 and Grade 2 Advanced GEP-NET

Somatostatin Receptor Positive (SSTR+), Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET) Phase3 United States

Multiple Sclerosis Patient Experience on Kesimpta and Ocrevus Subcutaneous Formulation

Multiple Sclerosis United States

RWE,NIS,Prospective Study for the Effectiveness, Tolerability and Adherence of Asciminib in Saudi Arabia. (ASC4REAL)

Chronic Myelogenous Leukemia in Chronic Phase Saudi Arabia

Study of Remibrutinib (LOU064) Efficacy and Safety and Exploration of Its Mechanism of Action in Participants With Chronic Urticaria

Chronic Urticaria (CU): Chronic Inducible Urticaria (CINDU) and Chronic Spontaneous Urticaria (CSU) Phase2 United States

A Study to Identify an Optimal Dose of QCZ484 in Mild to Moderate Hypertensive Patients

Hypertension Phase2 Singapore
United States

A Study of Efficacy, Safety, Tolerability of LXE408 in Participants With Chronic Chagas Disease.

Chagas Disease Phase2 Argentina
Colombia

A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas

Advanced Solid Tumor, Diffuse Large B Cell Lymphoma, Lymphoma, T-Cell, Mesothelioma, Malignant, Prostatic Neoplasms, Castration-Resistant, Endometrial Cancer, Ovarian Clear Cell Carcinoma, Metastatic Castration-resistant Prostate Cancer Phase1, Phase2 France
Italy
Korea, Republic of
Poland
Spain
United Kingdom
United States
View All

Phase IIIb Study of Ribociclib + ET in Early Breast Cancer

Early Breast Cancer Phase3 Australia
Hong Kong
Israel
Korea, Republic of
Taiwan
Turkey
United States
View All

DFT383 in Pediatric Participants With Nephropathic Cystinosis

Nephropathic Cystinosis Phase1, Phase2 United States

A Mobile App-Based Study to Evaluate Disease Burden and Treatment Patterns in Immunoglobulin A Nephropathy (IgAN) in the US

Immunoglobulin A Nephropathy United States